Matricelf Israeli Company
Matricelf has developed a technology that enables the production of autologous engineered tissue composed of matrix and cells derived from patients omental biopsies. In 2019, Matricelf licensed the technology that enabled scientists at Tel Aviv university to 3D print a human heart from human cells and matrix for the first time in history.
Health Tech & Life Sciences
Biotechnology
Health Care
Medical Device
Therapeutics
3D Technology
Alternatives
No alternatives listed yet.
AI-Generated Alternatives
Powered by AI May contain mistakes
AI is thinking and generating alternatives...
Suggest an Alternative
Founders
Parent Companies/Investors
References
[1]
finder.startupnationcentral.org
- https://finder.startupnationcentral.org/company_page/matricelf
[2]
crunchbase.com
- https://www.crunchbase.com/organization/matricelf
External links are provided for reference and verification purposes.